Translate Bio Inc.

Telesis Bio, Inc. develops and sells cutting‑edge synthetic biology platforms—BioXp 3250/9600 for digital DNA/mRNA production with integrated NGS—alongside kits and custom Gibson assembly, serving pharma, academia, and government, and is licensed by Regeneron.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 39
HQ: San Diego

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
TBIO	Translate Bio Inc. Cap: 0.0B	EQUITY	NMS	USD	US89374L1044	Active	📈